Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL337246 |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
CCR2/C-C chemokine receptor type 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4015] [GtoPdb: 59] [UniProtKB: P41597] | ||||||||
ChEMBL | Binding affinity of compound (10 uM) towards T292A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 5.11 | pKi | 7762.47 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards H121A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 5.59 | pKi | 2570.4 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards Y1210A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 5.74 | pKi | 1819.7 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards D284A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 6.14 | pKi | 724.44 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards H121F receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 6.18 | pKi | 660.69 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards WT receptor variant (mutant C-C chemokine receptor type 2) using radioligand [125I]MCP-1 in HEK 293 cells | B | 6.47 | pKi | 338.84 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards Y49F receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 6.5 | pKi | 316.23 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Binding affinity of compound (10 uM) towards Q288A receptor variant (mutant CCR2 receptor) using radioligand [125I]MCP-1 in HEK 293 cells | B | 6.5 | pKi | 316.23 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
GtoPdb | - | - | 6.5 | pKi | - | - | - | J Med Chem (2003) 46: 4070-86 [PMID:12954060] |
ChEMBL | Binding displacement of [125I]MCP-1 (0.14 nM) was measured on CHO cell membranes expressing human CCR2 (C-C chemokine receptor type 2) | B | 6.54 | pKi | 288.4 | nM | Ki | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Displacement of [125I]MCP1 from human CCR2B receptor expressed in HEK293-EBNA cells | B | 6.21 | pIC50 | 610 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662] |
ChEMBL | Antagonist activity at human CCR2B receptor expressed in HEK293 cells assessed as inhibition of MCP1-induced increase in intracellular calcium level | F | 6.52 | pIC50 | 300 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662] |
ChEMBL | Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of MCP1-induced chemotaxis after 1 hr by crystal violet staining | F | 7.15 | pIC50 | 70 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 2099-2102 [PMID:20223662] |
ChEMBL | Displacement of [125I]MCP1 from human CCR2b in THP1 cells | B | 7.27 | pIC50 | 54 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 1869-1873 [PMID:18313297] |
ChEMBL | Inhibitory activity against C-C chemokine receptor type 2 (antagonist activity) | F | 7.27 | pIC50 | 54 | nM | IC50 | J Med Chem (2003) 46: 4070-4086 [PMID:12954060] |
ChEMBL | Displacement of [125]MCP1 from CCR2 in human PBMCs | B | 7.77 | pIC50 | 17 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 5455-5461 [PMID:17720492] |
ChEMBL | Antagonist activity at human CCR2 in THP1 cells assessed as inhibition of MCP1-induced chemotaxis | F | 7.8 | pIC50 | 16 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 1869-1873 [PMID:18313297] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]